Matthew Chen serves as Executive at Longevity Acquisition Corp, where they oversee executive responsibilities. Since joining the company, Matthew Chen has executed 1 insider transactions totaling $2.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 31, 2018 involved purchasing 250,000 shares valued at $2.5M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 31, 2018 | LOACU | $2.5M | Purchase | 250,000 | $10.00 | Discretionary |
Matthew Chen currently holds 1,400,000 shares of Longevity Acquisition Corp (LOACU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Chen has been a net buyer of LOACU stock. They have purchased $2.5M and sold $0 worth of shares.
Matthew Chen's most recent insider trade was on Aug 31, 2018, when they purchased 250,000 shares at $10.00 per share.
Get notified when new Form 4 filings are submitted